First Department of Obstetrics and Gynecology, Laboratory of Genetics, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Ring Road, Nea Efkarpia, 56403 Thessaloniki, Greece.
Karolinska Institutet, Department of Clinical Sciences, Intervention and Technology, Unit of Obstetrics and Gynecology, K57 Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.
Hum Reprod Update. 2019 Nov 5;25(6):777-801. doi: 10.1093/humupd/dmz025.
Genomic imprinting is an epigenetic gene regulatory mechanism; disruption of this process during early embryonic development can have major consequences on both fetal and placental development. The periconceptional period and intrauterine life are crucial for determining long-term susceptibility to diseases. Treatments and procedures in assisted reproductive technologies (ART) and adverse in-utero environments may modify the methylation levels of genomic imprinting regions, including insulin-like growth factor 2 (IGF2)/H19, mesoderm-specific transcript (MEST), and paternally expressed gene 10 (PEG10), affecting the development of the fetus. ART, maternal psychological stress, and gestational exposures to chemicals are common stressors suspected to alter global epigenetic patterns including imprinted genes.
Our objective is to highlight the effect of conception mode and maternal psychological stress on fetal development. Specifically, we monitor fetal programming, regulation of imprinted genes, fetal growth, and long-term disease risk, using the imprinted genes IGF2/H19, MEST, and PEG10 as examples. The possible role of environmental chemicals in genomic imprinting is also discussed.
A PubMed search of articles published mostly from 2005 to 2019 was conducted using search terms IGF2/H19, MEST, PEG10, imprinted genes, DNA methylation, gene expression, and imprinting disorders (IDs). Studies focusing on maternal prenatal stress, psychological well-being, environmental chemicals, ART, and placental/fetal development were evaluated and included in this review.
IGF2/H19, MEST, and PEG10 imprinted genes have a broad developmental effect on fetal growth and birth weight variation. Their disruption is linked to pregnancy complications, metabolic disorders, cognitive impairment, and cancer. Adverse early environment has a major impact on the developing fetus, affecting mostly growth, the structure, and subsequent function of the hypothalamic-pituitary-adrenal axis and neurodevelopment. Extensive evidence suggests that the gestational environment has an impact on epigenetic patterns including imprinting, which can lead to adverse long-term outcomes in the offspring. Environmental stressors such as maternal prenatal psychological stress have been found to associate with altered DNA methylation patterns in placenta and to affect fetal development. Studies conducted during the past decades have suggested that ART pregnancies are at a higher risk for a number of complications such as birth defects and IDs. ART procedures involve multiple steps that are conducted during critical windows for imprinting establishment and maintenance, necessitating long-term evaluation of children conceived through ART. Exposure to environmental chemicals can affect placental imprinting and fetal growth both in humans and in experimental animals. Therefore, their role in imprinting should be better elucidated, considering the ubiquitous exposure to these chemicals.
Dysregulation of imprinted genes is a plausible mechanism linking stressors such as maternal psychological stress, conception using ART, and chemical exposures with fetal growth. It is expected that a greater understanding of the role of imprinted genes and their regulation in fetal development will provide insights for clinical prevention and management of growth and IDs. In a broader context, evidence connecting impaired imprinted gene function to common diseases such as cancer is increasing. This implies early regulation of imprinting may enable control of long-term human health, reducing the burden of disease in the population in years to come.
基因组印迹是一种表观遗传基因调控机制;在胚胎早期发育过程中,这一过程的中断会对胎儿和胎盘的发育产生重大影响。受孕前阶段和宫内生活对决定长期疾病易感性至关重要。辅助生殖技术(ART)中的治疗和程序以及不良的宫内环境可能会改变基因组印迹区域的甲基化水平,包括胰岛素样生长因子 2(IGF2)/H19、中胚层特异性转录物(MEST)和父系表达基因 10(PEG10),从而影响胎儿的发育。ART、产妇心理压力和妊娠期接触化学物质是常见的应激源,据推测它们会改变包括印迹基因在内的全局表观遗传模式。
我们的目的是强调受孕方式和产妇心理压力对胎儿发育的影响。具体而言,我们将使用 IGF2/H19、MEST 和 PEG10 等印迹基因作为范例,监测胎儿编程、印迹基因调控、胎儿生长和长期疾病风险。还讨论了环境化学物质在基因组印迹中的可能作用。
使用搜索术语 IGF2/H19、MEST、PEG10、印迹基因、DNA 甲基化、基因表达和印迹障碍(IDs),对 2005 年至 2019 年发表的文章进行了 PubMed 搜索。评估并纳入了专注于产妇产前压力、心理健康、环境化学物质、ART 和胎盘/胎儿发育的研究。
IGF2/H19、MEST 和 PEG10 印迹基因对胎儿生长和出生体重变化具有广泛的发育作用。它们的破坏与妊娠并发症、代谢紊乱、认知障碍和癌症有关。不良的早期环境对发育中的胎儿有重大影响,主要影响下丘脑-垂体-肾上腺轴和神经发育的结构和随后的功能。大量证据表明,妊娠环境会影响包括印迹在内的表观遗传模式,从而导致后代出现不良的长期后果。已经发现,产妇产前心理压力等环境应激源与胎盘 DNA 甲基化模式的改变有关,并影响胎儿发育。过去几十年的研究表明,ART 妊娠存在多种并发症的风险较高,例如出生缺陷和 IDs。ART 程序涉及多个步骤,这些步骤在印迹建立和维持的关键窗口中进行,因此需要对通过 ART 受孕的儿童进行长期评估。接触环境化学物质会影响人类和实验动物的胎盘印迹和胎儿生长。因此,应更好地阐明其在印迹中的作用,因为这些化学物质无处不在。
印迹基因的失调是一种合理的机制,它将产妇心理压力等应激源、使用 ART 受孕和化学物质暴露与胎儿生长联系起来。预计对印迹基因及其在胎儿发育中的调控作用的进一步了解将为生长和 IDs 的临床预防和管理提供依据。从更广泛的角度来看,越来越多的证据表明,受损的印迹基因功能与癌症等常见疾病有关。这意味着早期调控印迹可能会控制人类的长期健康,从而减轻未来人口疾病的负担。